{"title":"阿片耐受性的机制","authors":"David J. Mayer, Jianren Mao","doi":"10.1016/S1082-3174(99)70014-0","DOIUrl":null,"url":null,"abstract":"<div><p>This Commentary evaluates several observations and hypotheses made by Fundytus and Coderre: (1) Initial treatment with high doses of μ-opioid agonists decrease phosphatidlylinositol (PI) hydrolysis, while (2) chronic treatment increases PI hydrolysis to near control levels via increased activity of type I metabotropic glutamate receptors (mGluRs) and/or δ-opioid receptors. (3) The resulting inositol 1,4,5-trisphosphate-mediated increase in protein kinase C then phosphorylates a μ-opioid coupled G-protein, leading to a desensitization of μ-opioid receptors; phosphorylates N-methyl-D-aspartate (NMDA) receptor-associated Ca<sup>2+</sup> channels, resulting in a release of these channels from an Mg<sup>2+</sup> block; and increases Ca<sup>2+</sup>/calmodulin-dependent protein kinase, which produces additional phosphorylation of μ-opioid coupled G-protein, leading to further desensitization of μ-opioid receptors. (4) A role for type II/III mGluRs in opioid dependence occurs from desensitization of these receptors, which allows 3′,5′-cyclic adenosine monophosphate to remain at levels high enough to produce withdrawal symptoms. (5) Second messenger systems interact. We then review some of the observations with which a model of opioid tolerance should be consistent. Finally, we review a model for opioid tolerance that we recently proposed.</p></div>","PeriodicalId":101001,"journal":{"name":"Pain Forum","volume":"8 1","pages":"Pages 14-18"},"PeriodicalIF":0.0000,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-3174(99)70014-0","citationCount":"20","resultStr":"{\"title\":\"Mechanisms of opioid tolerance\",\"authors\":\"David J. Mayer, Jianren Mao\",\"doi\":\"10.1016/S1082-3174(99)70014-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This Commentary evaluates several observations and hypotheses made by Fundytus and Coderre: (1) Initial treatment with high doses of μ-opioid agonists decrease phosphatidlylinositol (PI) hydrolysis, while (2) chronic treatment increases PI hydrolysis to near control levels via increased activity of type I metabotropic glutamate receptors (mGluRs) and/or δ-opioid receptors. (3) The resulting inositol 1,4,5-trisphosphate-mediated increase in protein kinase C then phosphorylates a μ-opioid coupled G-protein, leading to a desensitization of μ-opioid receptors; phosphorylates N-methyl-D-aspartate (NMDA) receptor-associated Ca<sup>2+</sup> channels, resulting in a release of these channels from an Mg<sup>2+</sup> block; and increases Ca<sup>2+</sup>/calmodulin-dependent protein kinase, which produces additional phosphorylation of μ-opioid coupled G-protein, leading to further desensitization of μ-opioid receptors. (4) A role for type II/III mGluRs in opioid dependence occurs from desensitization of these receptors, which allows 3′,5′-cyclic adenosine monophosphate to remain at levels high enough to produce withdrawal symptoms. (5) Second messenger systems interact. We then review some of the observations with which a model of opioid tolerance should be consistent. Finally, we review a model for opioid tolerance that we recently proposed.</p></div>\",\"PeriodicalId\":101001,\"journal\":{\"name\":\"Pain Forum\",\"volume\":\"8 1\",\"pages\":\"Pages 14-18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1082-3174(99)70014-0\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pain Forum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1082317499700140\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Forum","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1082317499700140","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20
摘要
这篇评论对Fundytus和Coderre提出的几个观察和假设进行了评估:(1)高剂量μ-阿片受体激动剂的初始治疗减少了磷脂酰肌醇(PI)的水解,而(2)慢性治疗通过增加I型代谢型谷氨酸受体(mGluRs)和/或δ-阿片受体的活性,使PI水解接近控制水平。(3)肌醇1,4,5-三磷酸介导的蛋白激酶C的增加使μ-阿片偶联g蛋白磷酸化,导致μ-阿片受体脱敏;磷酸化n -甲基- d -天冬氨酸(NMDA)受体相关的Ca2+通道,导致这些通道从Mg2+阻滞中释放;增加Ca2+/钙调素依赖性蛋白激酶,使μ-阿片样物质偶联g蛋白磷酸化,导致μ-阿片样物质受体进一步脱敏。(4) II/III型mGluRs在阿片类药物依赖中的作用源于这些受体的脱敏,这使得3 ',5 ' -环腺苷单磷酸保持在足以产生戒断症状的高水平。(5)第二信使系统相互作用。然后,我们回顾了一些与阿片类药物耐受性模型应该一致的观察结果。最后,我们回顾了我们最近提出的阿片类药物耐受性模型。
This Commentary evaluates several observations and hypotheses made by Fundytus and Coderre: (1) Initial treatment with high doses of μ-opioid agonists decrease phosphatidlylinositol (PI) hydrolysis, while (2) chronic treatment increases PI hydrolysis to near control levels via increased activity of type I metabotropic glutamate receptors (mGluRs) and/or δ-opioid receptors. (3) The resulting inositol 1,4,5-trisphosphate-mediated increase in protein kinase C then phosphorylates a μ-opioid coupled G-protein, leading to a desensitization of μ-opioid receptors; phosphorylates N-methyl-D-aspartate (NMDA) receptor-associated Ca2+ channels, resulting in a release of these channels from an Mg2+ block; and increases Ca2+/calmodulin-dependent protein kinase, which produces additional phosphorylation of μ-opioid coupled G-protein, leading to further desensitization of μ-opioid receptors. (4) A role for type II/III mGluRs in opioid dependence occurs from desensitization of these receptors, which allows 3′,5′-cyclic adenosine monophosphate to remain at levels high enough to produce withdrawal symptoms. (5) Second messenger systems interact. We then review some of the observations with which a model of opioid tolerance should be consistent. Finally, we review a model for opioid tolerance that we recently proposed.